Journal of Clinical Densitometry

Journal

Publication Venue For

  • Use of Bone Health Evaluation in Orthopedic Surgery: 2019 ISCD Official Position.  22:517-543. 2019
  • Statistical Models to Assess Leg Muscle Mass in Ambulatory Children With Spastic Cerebral Palsy Using Dual-Energy X-Ray Absorptiometry.  22:391-400. 2019
  • Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region 2019
  • Greater Visceral Fat but No Difference in Measures of Total Body Fat in Ambulatory Children With Spastic Cerebral Palsy Compared to Typically Developing Children. 2018
  • Dual-energy X-ray Absorptiometry Quality Matters.  21:155-156. 2018
  • Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial.  20:464-471. 2017
  • Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.  20:8-24. 2017
  • Combining Computed Tomography-Based Bone Density Assessment with FRAX Screening in Men with Prostate Cancer.  19:430-435. 2016
  • Comparison of the Lunar Prodigy and iDXA Dual-Energy X-ray Absorptiometers for Assessing Total and Regional Body Composition.  19:290-297. 2016
  • Comparison of the Lunar Prodigy and iDXA Dual-Energy X-ray Absorptiometers for Assessing Total and Regional Body Composition..  19:290-297. 2016
  • Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance.  19:127-140. 2016
  • DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women.  18:145-149. 2015
  • The Effect of Extending Femur Scan Length on BMD Results on the Hologic Discovery-W Scanner.  17:518-521. 2014
  • Celiac Disease and Metabolic Bone Disease.  16:439-444. 2013
  • Dietary Supplements and Medical Foods for Osteopenia and Osteoporosis.  16:394-401. 2013
  • Divergent Effects of Obesity on Bone Health.  16:450-454. 2013
  • Eating Disorders and Bone.  16:432-438. 2013
  • Introduction From the Guest Editors.  16:387-388. 2013
  • Nutrition Counseling for Patients With Osteoporosis: A Personal Approach.  16:426-431. 2013
  • Acute Bone Marker Responses to Whole-Body Vibration and Resistance Exercise in Young Women.  16:104-109. 2013
  • Proceedings of the 2011 Santa Fe Bone Symposium.  15:1-20. 2012
  • Rheumatoid Arthritis is Associated With Less Optimal Hip Structural Geometry.  15:39-48. 2012
  • Validation of Diagnostic Codes for Subtrochanteric, Diaphyseal, and Atypical Femoral Fractures Using Administrative Claims Data.  15:92-102. 2012
  • Which to Use to Evaluate Change in BMD at Follow-Up: RMS-SD or RMS-%CV?.  15:26-31. 2012
  • Shorter Sleep may be a Risk Factor for Impaired Bone Mass Accrual in Childhood.  14:453-457. 2011
  • Official Positions for FRAX® Clinical Regarding Glucocorticoids: The impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture. From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®M.  14:212-219. 2011
  • Long-Term Versus Short-Term Precision of Dual-Energy X-Ray Absorptiometry Scans and the Impact on Interpreting Change in Bone Mineral Density at Follow-up.  14:108-115. 2011
  • Trends in Dual-Energy X-Ray Absorptiometry in the United States, 2000-2009.  14:100-107. 2011
  • Official Positions for FRAX® Clinical Regarding International Differences. From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.  14:240-262. 2011
  • Distribution of Z-Scores in a university cohort with an emphasis on "high" bone mineral density.  13:385-391. 2010
  • Osteoporosis care in the United States after declines in reimbursements for DXA.  13:352-360. 2010
  • Muscle Mass Is More Strongly Related to Hip Bone Mineral Density Than Is Quadriceps Strength or Lower Activity Level in Adults Over Age 50 Year.  11:503-510. 2008
  • Regional Variation in the Denial of Reimbursement for Bone Mineral Density Testing Among US Medicare Beneficiaries.  11:568-574. 2008
  • The Effect of Peritoneal Dialysate on DXA Bone Densitometry Results in Patients with End-Stage Renal Disease.  11:532-536. 2008
  • "Black Hole Artifacts"-A New Potential Pitfall for DXA Accuracy?.  11:266-275. 2008
  • Comparing BMD Results Between Two Similar DXA Systems Using the Generalized Least Significant Change.  11:237-242. 2008
  • The Effect of Common Artifacts Lateral to the Spine on Bone Mineral Density in the Lumbar Spine.  11:243-249. 2008
  • Nonprogression of Vertebral Area or Bone Mineral Content on DXA Does Not Predict Compression Fractures.  9:261-264. 2006
  • Need for precision studies at individual institutions and assessment of size of regions of interest on serial DXA scans.  6:97-101. 2003
  • A normative reference database study for Pronosco X-posure System™.  4:5-12. 2001
  • International Standard Serial Number (issn)

  • 1094-6950
  • Electronic International Standard Serial Number (eissn)

  • 1559-0747